“A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way,” Alex Janin writes over at The Wall Street Journal. “Instead, some compounding pharmacies and telehealth companies that make the copies have found new ways in. They are making […]
